UP FSDA Finds Large Price Gaps Between Purchase Cost and MRP of Medicines
An inspection by the Uttar Pradesh Food Safety and Drug Administration (FSDA) found significant disparities between purchase prices and maximum retail prices (MRPs) of medicines in 214 hospital pharmacies. Polymyxin-B injection showed the largest gap, with an MRP nearly 67 times its purchase cost. Other drugs for serious infections and critical conditions also exhibited MRPs exceeding purchase prices by over 10 times. The FSDA has sought explanations from hospitals, suppliers, and manufacturers regarding these pricing differences.
First-hand measurement across 3 sources
We measured how 3 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (40/100). Lens Score 55/100.
Outlets measured: freepressjournal, hindustantimes, hindustantimes. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (28–42/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
hindustantimes broke this story on 4 Oct, 02:20 am. Other outlets followed.